Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Return on Assets: 2014-2025

Historic Return on Assets for Theravance Biopharma (TBPH) over the last 12 years, with Sep 2025 value amounting to 0.05%.

  • Theravance Biopharma's Return on Assets rose 19.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 19.00%. This contributed to the annual value of -0.17% for FY2024, which is 6.00% down from last year.
  • Latest data reveals that Theravance Biopharma reported Return on Assets of 0.05% as of Q3 2025, which was up 262.77% from 0.01% recorded in Q2 2025.
  • Over the past 5 years, Theravance Biopharma's Return on Assets peaked at 1.81% during Q2 2023, and registered a low of -0.49% during Q1 2021.
  • For the 3-year period, Theravance Biopharma's Return on Assets averaged around 0.23%, with its median value being -0.12% (2024).
  • Per our database at Business Quant, Theravance Biopharma's Return on Assets surged by 184bps in 2022 and then plummeted by 194bps in 2024.
  • Theravance Biopharma's Return on Assets (Quarterly) stood at 0.17% in 2021, then spiked by 124bps to 1.41% in 2022, then tumbled by 155bps to -0.14% in 2023, then fell by 4bps to -0.18% in 2024, then climbed by 19bps to 0.05% in 2025.
  • Its Return on Assets was 0.05% in Q3 2025, compared to 0.01% in Q2 2025 and -0.19% in Q1 2025.